Skip to playerSkip to main content
  • 4 weeks ago
A study conducted by Texas A&M University has revealed that anthocyanins derived from dark sweet cherries are linked to a decrease in tumor growth and lowered metastasis in a mouse model of triple-negative breast cancer. These compounds were found to influence gene expression related to cancer dissemination and resistance to treatment. Mice treated with anthocyanins exhibited reduced lung metastasis, as well as diminished spread to the liver, heart, kidneys, and spleen. The research involved a comparison across four groups, including those receiving anthocyanin treatment, chemotherapy, or a combination of both. These initial findings warrant further investigation into safety, absorption, and the potential integration of these compounds with established therapies.
Disclosure:This video contains stock footage and content created or enhanced using Ai-assisted tools ai-generated

Category

🗞
News
Transcript
00:00Scientists at Texas A&M University have found a potential cancer-fighting effect in dark-sweet
00:05cherries. Their study focused on anthocyanins, natural pigments that give cherries their deep
00:11red color. In mice with triple-negative breast cancer, these compounds were linked to slower
00:16tumor growth. Researchers also found less cancer spread to several organs, including the lungs.
00:22Anthocyanins also changed gene activity connected to metastasis and treatment resistance. The study
00:28tested anthocyanins alone, chemotherapy, and a combination of both approaches. Mice receiving
00:34the combination showed earlier slowing of tumor growth while maintaining body weight. However,
00:40these results are from animal research and do not prove cherries can treat cancer in people.
00:45Researchers say more studies are needed to understand safety, absorption, and potential
00:50use alongside cancer treatments. Disclosure. This video contains stock footage and content
00:55created or enhanced using AI-assisted tools AI generated.

Recommended